Delivery Order SPE2DB20D9354-SPE2DB25FX7X5
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency (DLA) on May 6, 2025. The delivery order, which represents a single issuance under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA, covers the supply of Trikafta (a prescription medication used to treat cystic fibrosis) in the 100-50-75 mg/150 mg...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency (DLA) on July 14, 2025. The delivery order, which is scheduled for completion by July 15, 2025, covers the supply of Trikafta 100-50-75 mg/150 mg tablets in a quantity of 84 units. This award was issued without set-aside designation and represents a single delivery order under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $36,976.24 by the Defense Logistics Agency (DLA) on July 31, 2025, with an ultimate completion date of August 1, 2025. The delivery order, issued under a firm fixed-price contract structure with no set-aside designation, covers the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). Performance will occur at the contractor's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $18,488.12 by the Defense Logistics Agency for Trikafta 100-50-75 mg/150 mg tablets (84 units). This firm fixed-price delivery order, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a direct pharmaceutical supply fulfillment under DMS Pharmaceutical Group's existing Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $75,595.28 by the Defense Logistics Agency (DLA) on September 11, 2025, with a completion date of September 12, 2025. The delivery order covers Trikafta 100-50-75 mg/75 mg packets in quantities of 14, a prescription medication used in the treatment of cystic fibrosis. This award was made without a set-aside designation,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $112,587.38 by the Defense Logistics Agency on September 2, 2025, with an ultimate completion date of September 3, 2025. The contract covers the supply of Trikafta 100-50-75 mg/75 mg packets in quantities of 14, a prescription medication used in the treatment of cystic fibrosis. This delivery order was issued without a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $18,488.12 by the Defense Logistics Agency (DLA) for Trikafta 100-50-75 mg/150 mg tablets. This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a direct fulfillment of pharmaceutical supply needs for federal healthcare systems. The award carries no set-aside...
- The Defense Logistics Agency (DLA) awarded a $18,488.12 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Trikafta 100-50-75 mg/150 mg, a cystic fibrosis treatment medication. The delivery order, issued on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a targeted pharmaceutical procurement without set-aside designation. DMS Pharmaceutical Group...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $19,316.57 by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Trikafta 100-50-75 mg/75 mg packets in quantities of 14. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, was issued without a set-aside designation. The contract represents a continuation of DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency on September 8, 2025, for the supply of Trikafta 100-50-75 mg/150 mg tablets (84-count units). The delivery order carries an ultimate completion date of September 9, 2025, and represents no set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite...
- SPE2DB20D9354Indefinite Delivery Contract
- SPE2DB20D9354-SPE2DB25FX7X5Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on August 26, 2025, valued at $18,488.12. The delivery order, which carries no set-aside designation, is for Trikafta 100-50-75 mg/150 mg tablets, a prescription medication used in the treatment of cystic fibrosis. The order is scheduled for completion by August 27, 2025, with performance taking place at the contractor's Park Ridge facility. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. Through this master contract vehicle, the DLA can issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs across military health facilities worldwide. DMS Pharmaceutical Group's established position as a pharmaceutical supplier to federal agencies, combined with its woman-owned small business status, has enabled the company to maintain consistent engagement in defense pharmaceutical procurement markets.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.5k | 8/26/25 |